Skip to content
The Nexus
DossierENTITY

Mochi Health

Coverage of Mochi Health in the Nexus archive.

Earliest in view: Jun 4 · 11:30 UTCMost recent: Jun 4 · 11:30 UTC
Co-mentioned in this coverage
Aqueita Pharmacyorganization1Myrah Ahmadperson1GLP-1 compoundstopic1Washington Department of Healthorganization1NBC Bay Area Investigative Unitorganization1King 5organization1
Recent coverage
  • HEALTHJun 4 · 11:30 UTCNBC BAY AREA
    Are GLP-1 compounds safe? Not from this company and supplier, whistleblowers say

    Mochi Health, a San Francisco-based weight loss startup, faces scrutiny for partnering with Aqueita Pharmacy to produce GLP-1 compounded medications. Whistleblowers allege Aqueita used unlicensed workers, allowed improper compounding practices, and shipped unsafe products with glass particles and expired drugs. The FDA warns these non-approved compounds pose risks.

Mochi Health · Dossier · The Nexus